Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects

Hypertension Research

Volumn 34, Issue 7, 2011, Pages 840-845

  Yamato, Mayumi ^a,b   Shiba, Takeshi ^c   Ide, Tomomi ^a   Honda, Youhei ^c   Yamada, Ken Ichi ^c   Tsutsui, Hiroyuki ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

calcium channel blocker; free radical; ischemia reperfusion; nifedipine; stroke

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDE; NIFEDIPINE; THIOBARBITURIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERTENSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN ISCHEMIA; MALE; MITOCHONDRIA; NIFEDIPINE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY; STROKE;

EID: 79959997044     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.51     Document Type: Article

References (33)

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
2. Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ, McTaggart RA, Choudhri TF, Kim LJ, Mocco J, Pinsky DJ, Fox WD, Israel RJ, Boyd TA, Golde DW, Connolly Jr ES. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci USA 2001; 98: 11720-11724. (Pubitemid 32928795)
3. Kato N, Yanaka K, Hyodo K, Homma K, Nagase S, Nose T. Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res 2003; 979: 188-193. (Pubitemid 36792169)
4. Yamato M, Egashira T, Utsumi H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic Biol Med 2003; 35: 1619-1631. (Pubitemid 37532913)
5. Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 2006; 273: 433-450.
6. Tjong YW, Jian K, Li M, Chen M, Gao TM, Fung ML. Elevated endogenous nitric oxide increases Ca2+ flux via L-type Ca2+ channels by S-nitrosylation in rat hippocampal neurons during severe hypoxia and in vitro ischemia. Free Radic Biol Med 2007; 42: 52-63. (Pubitemid 44842008)
7. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008; 55: 310-318.
8. Seeburg PH. The TINS/TiPS lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 1993; 16: 359-365. (Pubitemid 23232009)
9. Abe K, Kogure K, Watanabe T. Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200-110). J Cereb Blood Flow Metab 1988; 8: 436-439.
10. Lukic-Panin V, Kamiya T, Zhang H, Hayashi T, Tsuchiya A, Sehara Y, Deguchi K, Yamashita T, Abe K. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats. Brain Res 2007; 1176: 143-150. (Pubitemid 47553120)
11. Mogi M, Iwai M, Chen R, Iwanami J, Ide A, Tsukuda K, Yoshii T, Horiuchi M. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. Am J Hypertens 2006; 19: 1144-1149. (Pubitemid 44633592)
12. Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006; 29: 457-466. (Pubitemid 44109037)
13. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8: 1-8.
14. Yamato M, Shiba T, Yamada K, Watanabe T, Utsumi H. Noninvasive assessment of the brain redox status after transient middle cerebral artery occlusion using Overhauserenhanced magnetic resonance imaging. J Cereb Blood Flow Metab 2009; 29: 1655-1664.
15. Kollmar R, Schabitz WR, Heiland S, Georgiadis D, Schellinger PD, Bardutzky J, Schwab S. Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study. Stroke 2002; 33: 1899-1904. (Pubitemid 34761082)
16. Peeling J, Corbett D, Del Bigio MR, Hudzik TJ, Campbell TM, Palmer GC. Rat middle cerebral artery occlusion: correlations between histopathology, T2-weighted magnetic resonance imaging, and behavioral indices. J Stroke Cerebrovasc Dis 2001; 10: 166-177. (Pubitemid 34098126)
17. Schabitz WR, Schade H, Heiland S, Kollmar R, Bardutzky J, Henninger N, Müller H, Carl U, Toyokuni S, Sommer C, Schwab S. Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke 2004; 35: 1175-1179. (Pubitemid 38543539)
18. Yamamoto Y, Takahashi K. Glutathione peroxidase isolated from plasma reduces phospholipid hydroperoxides. Arch Biochem Biophys 1993; 305: 541-545. (Pubitemid 23282943)
19. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975; 250: 5475-5480.
20. Flohe L, Otting F. Superoxide dismutase assays. Methods Enzymol 1984; 105: 93-104. (Pubitemid 14165376)
21. Fukuo K, Yang J, Suzuki T, Kaimoto T, Takemura Y, Yasuda O, Suhara T, Sato N, Ogihara T. Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell-dependent pathways. Hypertens Res 2003; 26: 503-508. (Pubitemid 36849732)
22. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996; 264: 484-509.
23. Hall ED, Andrus PK, Althaus JS, VonVoigtlander PF. Hydroxyl radical production and lipid peroxidation parallels selective post-ischemic vulnerability in gerbil brain. J Neurosci Res 1993; 34: 107-112. (Pubitemid 23014258)
24. Akaishi T, Nakazawa K, Sato K, Saito H, Ohno Y, Ito Y. Hydrogen peroxide modulates whole cell Ca2+ currents through L-type channels in cultured rat dentate granule cells. Neurosci Lett 2004; 356: 25-28. (Pubitemid 38121498)
25. Matsubara M, Hasegawa K. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 2005; 178: 57-66. (Pubitemid 39600816)
26. Matsubara M, Akizuki O, Ikeda J, Saeki K, Yao K, Sasaki K. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats. Eur J Pharmacol 2008; 580: 201-213.
27. El-Abhar HS, Shaalan M, Barakat M, El-Denshary ES. Effect of melatonin and nifedipine on some antioxidant enzymes and different energy fuels in the blood and brain of global ischemic rats. J Pineal Res 2002; 33: 87-94. (Pubitemid 34913485)
28. Mohan K, Dubey ML, Ganguly NK, Kalra A, Mahajan RC. Effect of nifedipine on oxidative damage of erythrocytes in Plasmodium berghei-infected mice. Clin Immunol Immunopathol 1993; 69: 244-247. (Pubitemid 23319393)
29. Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996; 27: 327-331; discussion 332.
30. van Bruggen N, Cullen BM, King MD, Doran M, Williams SR, Gadian DG, Cremer JE. T2-and diffusion-weighted magnetic resonance imaging of a focal ischemic lesion in rat brain. Stroke 1992; 23: 576-582.
31. van Bruggen N, Roberts TP, Cremer JE. The application of magnetic resonance imaging to the study of experimental cerebral ischaemia. Cerebrovasc Brain Metab Rev 1994; 6: 180-210.
32. Dijkhuizen RM, Nicolay K. Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab 2003; 23: 1383-1402. (Pubitemid 38018257)
33. Kato H, Kogure K, Ohtomo H, Izumiyama M, Tobita M, Matsui S, Yamamoto E, Kohno H, Ikebe Y, Watanabe T. Characterization of experimental ischemic brain edema utilizing proton nuclear magnetic resonance imaging. J Cereb Blood Flow Metab 1986; 6: 212-221. (Pubitemid 16109317)